Amy C Cannella

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?
    Amy C Cannella
    Division of Rheumatology, University of Utah, Salt Lake City, Utah 84117, USA
    Curr Opin Rheumatol 15:185-92. 2003
  2. ncbi Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials
    Amy C Cannella
    University of Nebraska Medical Center, Omaha, Nebraska 68198 3025, USA
    Drugs 66:1319-37. 2006

Collaborators

Detail Information

Publications2

  1. ncbi Is there still a role for traditional disease-modifying antirheumatic drugs (DMARDs) in rheumatoid arthritis?
    Amy C Cannella
    Division of Rheumatology, University of Utah, Salt Lake City, Utah 84117, USA
    Curr Opin Rheumatol 15:185-92. 2003
    ..The intent of this article is to review recent and relevant trials in the treatment of rheumatoid arthritis, suggest a treatment algorithm, and argue that traditional disease-modifying antirheumatic drugs continue to play a pivotal role...
  2. ncbi Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials
    Amy C Cannella
    University of Nebraska Medical Center, Omaha, Nebraska 68198 3025, USA
    Drugs 66:1319-37. 2006
    ..However, further research is needed to determine which regimen is appropriate for the individual patient with RA...